Merck

enlicitide-meets-all-endpoints-in-major-hypercholesterolemia-trial

Enlicitide Meets All Endpoints in Major Hypercholesterolemia Trial

Editorial 2 September, 2025

Merck has announced that its investigational oral PCSK9 inhibitor, enlicitide decanoate, has successfully met...

rfk-jr-s-panel-recommends-new-rsv-treatment-for-infants

RFK Jr’s Panel Recommends New RSV Treatment for Infants

Editorial 29 June, 2025

WASHINGTON, D.C. – In a significant move, Robert F. Kennedy Jr.’s revamped vaccine advisory...